In May 2026, Phase 3 topline results from the TRIUMPH-1 trial across 2,339 participants showed an average 28.3 percent body weight reduction over 80 weeks at the highest dose, with 45.3 percent of those participants losing at least 30 percent of body weight a threshold previously achievable only through surgery
Serving Size: 1 capsule
A practical pre-treatment checklist Confirm whether you already have diabetic retinopathy or diabetic macular edema Tell your endocrinologist or primary physician if you are under retina care Tell your eye doctor if you are about to start semaglutide or another GLP-1 drug Update your dilated eye exam if it is overdue Document baseline symptoms such as blur, floaters, or metamorphopsia This creates a baseline
Prepared receptor models were then processed in System Builder to define the simulation environment, assign default physiological ionization conditions, and were then subjected to a final restrained minimization to remove steric clashes and ensure structural relaxation before virtual screening calculations
About Team PureRawz Team PureRawz is dedicated to providing accurate, science-based information on research chemicals, including Peptides, Nootropics, and SARMs
See self-pay costs below
